Balaji Amines Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017
January 29, 2018 at 07:08 am
Share
Balaji Amines Limited reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2017. For the quarter, the company reported revenue from operations of INR 2,188.373 million compared to INR 1,802.199 million a year ago. Profit before exceptional items and tax was INR 449.883 million compared to INR 299.791 million a year ago. Profit before tax was INR 455.874 million compared to INR 302.167 million a year ago. Net profit was INR 280.866 million or INR 8.67 per basic and diluted share (not annualized) compared to INR 196.293 million or INR 6.05 per basic and diluted share (not annualized) a year ago.
For the nine months, the company reported revenue from operations of INR 6,201.002 million compared to INR 5,341.625 million a year ago. Profit before exceptional items and tax was INR 1,258.571 million compared to INR 961.0 million a year ago. Profit before tax was INR 1,264.562 million compared to INR 979.634 million a year ago. Net profit was INR 800.050 million or INR 24.69 per basic and diluted share (not annualized) compared to INR 677.008 million or INR 20.89 per basic and diluted share (not annualized) a year ago.
Balaji Amines Limited is an India-based company, which is engaged in the business of manufacturing of specialty chemicals, aliphatic amines and derivatives. The Companyâs segments include Amines & Specialty Chemicals and Hotel Division. It also owns a five-star Hotel in Solapur, Maharashtra. Its products include amines, derivatives, specialty chemicals and pharma excipients. Its amine products include MONOMETHYLAMINE (MMA), DIMETHYLAMINE (DMA), TRIMETHYLAMINE and others. Its specialty chemical products include N-Methyl Pyrrolidone (NMP), Morpholine, 2-PYRROLIDONE (2-P), N-ETHYL-2-PYRROLIDONE, GAMMA-BUTYROLACTONE, ACETONITRILE (ACN) and others. Its derivatives products include Di-Methyl Acetamide (DMAC); Di-Methyl Amine Hydrochloride (DMA HCL); Tri-Methyl Amine Hydrochloride (TMA HCL); Di-Ethyl Amine Hydrochloride (DEA HCL), and others. Its pharma excipients products include POLY VINYL PYRROLIDONE(PVP-30) IP/BP/JP GRADE and POLY VINYL PYRROLIDONE(PVP-30)-TECHNICAL GRADE.